Accession |
PRJCA016234 |
Title |
To evaluate the safety and tolerability of anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors |
Relevance |
Medical |
Data types |
clinical,image,Metabolic data
|
Organisms |
Homo sapiens
|
Description |
To evaluate the safety and tolerability of anti-PD-1 antibody SHR-1210 in patients with advanced solid tumors |
Sample scope |
Multiisolate |
Release date |
2023-04-13 |
Grants |
Agency |
program |
Grant ID |
Grant title |
NA
|
|
NA
|
|
|
Submitter |
wanqiu
liang (wanqiu.liang@hengrui.com)
|
Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
Submission date |
2023-04-13 |